Ipamorelin Solo: The Clean GH Pulse
Ipamorelin used alone is the most conservative approach to GH research. Its extreme selectivity means researchers can study GH effects in relative isolation:
Advantages of Solo Use: - Cleanest hormonal profile of any GH secretagogue - No meaningful impact on cortisol, prolactin, or appetite - Does not desensitise receptors as quickly as other ghrelin mimetics - Pulsatile release mimics the body's natural GH rhythm - Excellent for baseline GH research or first-time peptide protocols
Limitations of Solo Use: - GH pulses are discrete and relatively brief - Total 24-hour GH exposure is lower than with combination protocols - May not be sufficient for researchers studying aggressive body composition changes
ORYN Ipamorelin Pen: 6 mg, 30-day supply, EUR 109.
CJC-1295 Solo: Sustained GH Elevation
CJC-1295 alone produces a different GH profile -- sustained elevation rather than sharp pulses:
Advantages of Solo Use: - Extended GH elevation increases total daily GH exposure - Increases IGF-1 levels more consistently over time - Effective for researchers focused on body composition and recovery endpoints - Well-studied GHRH analogue with strong pharmacokinetic data
Limitations of Solo Use: - Less selective than Ipamorelin -- may affect cortisol and prolactin - Sustained elevation does not mimic natural pulsatile GH secretion - Water retention reported at higher doses - Receptor desensitisation may occur faster without pulsatile stimulation
ORYN CJC-1295 Pen: 5 mg, 30-day supply, EUR 109.
The Case for Stacking: Dual-Pathway Synergy
The CJC-1295 + Ipamorelin stack is considered the gold standard GH peptide protocol for a physiological reason:
Two Pathways, One Goal: Ipamorelin activates the ghrelin receptor to trigger GH pulses. CJC-1295 activates the GHRH receptor to amplify and sustain those pulses. Because they use different receptors, there is no competition -- they produce additive or synergistic effects.
Quantified Benefit: Research suggests the combination produces 2-3x greater total GH release compared to either peptide alone. The pulses triggered by Ipamorelin are amplified and extended by CJC-1295's GHRH activity.
Protocol Design: Administered simultaneously, typically before bed to align with the body's natural nocturnal GH secretion peak. Standard protocols run 8-12 weeks.
Balanced Profile: Ipamorelin's selectivity partially offsets CJC-1295's tendency to affect other hormones, resulting in a combination that is both more effective and better tolerated than CJC-1295 alone.
ORYN Stack Cost: EUR 109 + EUR 109 = EUR 218 for two 30-day pens. The most popular GH research stack on the ORYN platform.
